What We Need to Know about Liposomes as Drug Nanocarriers : An Updated Review
©2023 The Authors..
Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and length of circulation in biological fluids. This article provides an overview of the significant advances in synthesis of liposomes via active or passive drug loading methods, as well as describes some strategies developed to fabricate their targeted formulations to overcome limitations of the "first-generation" liposomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Advanced pharmaceutical bulletin - 13(2023), 1 vom: 27. Jan., Seite 7-23 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abbasi, Hanieh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 02.02.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.34172/apb.2023.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352321822 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352321822 | ||
| 003 | DE-627 | ||
| 005 | 20231226053442.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.34172/apb.2023.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1174.xml |
| 035 | |a (DE-627)NLM352321822 | ||
| 035 | |a (NLM)36721822 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abbasi, Hanieh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What We Need to Know about Liposomes as Drug Nanocarriers |b An Updated Review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©2023 The Authors. | ||
| 520 | |a Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and length of circulation in biological fluids. This article provides an overview of the significant advances in synthesis of liposomes via active or passive drug loading methods, as well as describes some strategies developed to fabricate their targeted formulations to overcome limitations of the "first-generation" liposomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Liposome | |
| 650 | 4 | |a Liposome applications | |
| 650 | 4 | |a Liposome loading methods | |
| 650 | 4 | |a Liposome synthesis | |
| 650 | 4 | |a Liposome targeting methods | |
| 700 | 1 | |a Kouchak, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Mirveis, Zohreh |e verfasserin |4 aut | |
| 700 | 1 | |a Hajipour, Fatemeh |e verfasserin |4 aut | |
| 700 | 1 | |a Khodarahmi, Mohsen |e verfasserin |4 aut | |
| 700 | 1 | |a Rahbar, Nadereh |e verfasserin |4 aut | |
| 700 | 1 | |a Handali, Somayeh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advanced pharmaceutical bulletin |d 2011 |g 13(2023), 1 vom: 27. Jan., Seite 7-23 |w (DE-627)NLM233419101 |x 2228-5881 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:27 |g month:01 |g pages:7-23 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.34172/apb.2023.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 1 |b 27 |c 01 |h 7-23 | ||